It is a global health concern characterized by various molecular subtypes, including Luminal A, Luminal B, human epidermal growth factor receptor 2 (HER-2), and triple-negative breast cancer (TNBC) [3]. Here, ERBB2 is linked to triple-negative breast carcinoma.